German Cancer Consortium
- Speaker LMU: Prof. Dr. Wolfgang Hiddemann
- Affiliation: Department of Medicine III, University Hospital, LMU Munich
Successful cancer research is inconceivable without intensive exchange between very different disciplines. This is why cancer research often takes place at large centres, some of which have more than 10,000 employees in the USA. The German Consortium for Translational Cancer Research is oriented towards such large research centres without abandoning the federal structures of German research. 21 institutions cooperate at eight locations. A core task of cancer research is to examine the results of basic research for new approaches to the prevention, diagnosis and treatment of cancer. At the DKTK's eight locations, scientists and doctors are committed to precisely this "translational" idea.
Munich is one of eight DKTK locations and is coordinated by Prof. Dr. Wolfgang Hiddemann and Prof. Dr. Christian Peschel. "It is our goal to gain new insights into the biology and pathogenesis of malignant tumors in close cooperation with the other partners of the DKTK and to implement these findings in innovative diagnostic and therapeutic procedures. In Munich, we are concentrating in a first step on tumors of the gastrointestinal tract and haematological neoplasias as well as on the analysis of oncogenic signal transmission pathways".